Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 12-2016 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 19,811 | 7,992 |
| Marketable Securities | N/A | 0 | 8,348 |
| Other current assets | 0 | 892 | 975 |
| TOTAL | $N/A | $20,703 | $17,315 |
| Non-Current Assets | |||
| Other Non-Current Assets | 0 | 310 | 0 |
| TOTAL | $N/A | $310 | $N/A |
| Total Assets | $N/A | $22,039 | $18,251 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 427 | 508 |
| Accrued Expenses | N/A | 804 | 458 |
| TOTAL | $N/A | $1,231 | $966 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 30 | 0 |
| TOTAL | $N/A | $30 | $N/A |
| Total Liabilities | $N/A | $1,261 | $966 |
| Shareholders' Equity | |||
| Retained earnings | N/A | -26,324 | -11,882 |
| Other shareholders' equity | 0 | 47,102 | 29,167 |
| TOTAL | $N/A | $20,778 | $17,285 |
| Total Liabilities And Equity | $0 | $22,039 | $18,251 |